Literature DB >> 28573369

Systolic and pulse pressure associate with incident knee osteoarthritis: data from the Osteoarthritis Initiative.

Grace H Lo1,2, Timothy E McAlindon3, Jeffrey N Katz4, Jeffrey B Driban3, Lori Lyn Price5,6, Charles B Eaton7,8, Nancy J Petersen9, Christie M Ballantyne10, Maria E Suarez-Almazor11.   

Abstract

We evaluated the relationship of systolic blood pressure, diastolic blood pressure, pulse pressure, and treatment with antihypertensives with knee osteoarthritis incidence in a US cohort. We performed a longitudinal study (2004-2010) nested within the Osteoarthritis Initiative Study including only individuals without knee osteoarthritis at baseline. Systolic blood pressure, diastolic blood pressure, and pulse pressure were assessed at baseline, 12-, 24-, and 36-month visits. Knee radiographs at baseline, 12-, 24-, 36- and 48-month visits defined radiographic osteoarthritis, Kellgren and Lawrence grade ≥2. We performed logistic regression, adjusting for age, sex, body mass index, NSAID use, number of antihypertensive medications, diabetic medications, and cholesterol medications. One thousand nine hundred and thirty people (6040 observations) were included. Annual incidence rates of radiographic osteoarthritis by systolic blood pressure quartiles (lowest to highest) were 2.1, 3.4, 3.7, and 3.7%. Fully adjusted odds ratios of incident radiographic osteoarthritis (OA) for the 2nd-4th quartiles were 1.6, 1.7, and 1.6 relative to the lowest quartile (p for trend = 0.03). Pulse pressure results were similar. There was no association with diastolic blood pressure. Compared to those not taking any antihypertensive medications, those taking ≥3 had decreased odds (0.4, 0.1-1.0) of developing incident OA. In a US cohort, higher systolic blood pressure and pulse pressure are associated with increased incidence of radiographic knee osteoarthritis while treatment with ≥3 antihypertensive medications was associated with reduced incidence. These findings suggest a new and promising avenue for research on disease modification in knee osteoarthritis.

Entities:  

Keywords:  Hypertension; Osteoarthritis; Pulse pressure

Mesh:

Substances:

Year:  2017        PMID: 28573369      PMCID: PMC5709188          DOI: 10.1007/s10067-017-3656-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  35 in total

1.  Self-instructional guide to the Iowa Drug Information Service.

Authors:  L A Wanke
Journal:  Drug Intell Clin Pharm       Date:  1977-11

2.  The relation between total joint arthroplasty and risk for serious cardiovascular events in patients with moderate-severe osteoarthritis: propensity score matched landmark analysis.

Authors:  Bheeshma Ravi; Ruth Croxford; Peter C Austin; Lorraine Lipscombe; Arlene S Bierman; Paula J Harvey; Gillian A Hawker
Journal:  Br J Sports Med       Date:  2014-11       Impact factor: 13.800

Review 3.  A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology.

Authors:  T E Towheed; M C Hochberg
Journal:  Semin Arthritis Rheum       Date:  1997-04       Impact factor: 5.532

4.  Retinal arteriolar narrowing and incidence of knee replacement for osteoarthritis: a prospective cohort study.

Authors:  S M Hussain; Y Wang; J E Shaw; D J Magliano; T Y Wong; A E Wluka; S Graves; R J Tapp; F M Cicuttini
Journal:  Osteoarthritis Cartilage       Date:  2015-01-14       Impact factor: 6.576

5.  Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis.

Authors:  A G Johnson; T V Nguyen; R O Day
Journal:  Ann Intern Med       Date:  1994-08-15       Impact factor: 25.391

6.  Knee arthroplasty in Denmark, Norway and Sweden. A pilot study from the Nordic Arthroplasty Register Association.

Authors:  Otto Robertsson; Svetlana Bizjajeva; Anne Marie Fenstad; Ove Furnes; Lars Lidgren; Frank Mehnert; Anders Odgaard; Alma Becic Pedersen; Leif Ivar Havelin
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

7.  A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure.

Authors:  J E Pope; J J Anderson; D T Felson
Journal:  Arch Intern Med       Date:  1993-02-22

8.  Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study.

Authors:  N Yoshimura; S Muraki; H Oka; S Tanaka; H Kawaguchi; K Nakamura; T Akune
Journal:  Osteoarthritis Cartilage       Date:  2012-07-14       Impact factor: 6.576

9.  Common problems experienced by adults with osteoarthritis.

Authors:  M Weinberger; W M Tierney; P Booher
Journal:  Arthritis Care Res       Date:  1989-09

10.  Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction.

Authors:  Sharon M L Wallace; Carmel M McEniery; Kaisa M Mäki-Petäjä; Anthony D Booth; John R Cockcroft; Ian B Wilkinson
Journal:  Hypertension       Date:  2007-05-14       Impact factor: 10.190

View more
  13 in total

Review 1.  Epidemiology of osteoarthritis: literature update.

Authors:  Ernest R Vina; C Kent Kwoh
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

2.  Metabolic syndrome, hypertension, and hyperglycemia were positively associated with knee osteoarthritis, while dyslipidemia showed no association with knee osteoarthritis.

Authors:  Yinhao Xie; Wei Zhou; Zhihong Zhong; Ziping Zhao; Haotao Yu; Yaxiang Huang; Ping Zhang
Journal:  Clin Rheumatol       Date:  2020-07-23       Impact factor: 2.980

Review 3.  Inflammaging and Osteoarthritis.

Authors:  Francesca Motta; Elisa Barone; Antonio Sica; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-18       Impact factor: 8.667

4.  A novel approach to studying early knee osteoarthritis illustrates that bilateral medial tibiofemoral osteoarthritis is a heritable phenotype: an offspring study.

Authors:  Grace H Lo; Michael J Richard; Jane A Cauley; Jeffrey B Driban; Michael Strayhorn; James MacKay; Matthew S Harkey; Timothy E McAlindon; Mary Jansen; Stephanie Green; Donna L White; C Kent Kwoh
Journal:  Rheumatol Int       Date:  2022-04-23       Impact factor: 3.580

Review 5.  Hypertension meets osteoarthritis - revisiting the vascular aetiology hypothesis.

Authors:  Karen Ching; Xavier Houard; Francis Berenbaum; Chunyi Wen
Journal:  Nat Rev Rheumatol       Date:  2021-07-27       Impact factor: 20.543

6.  Evidence that Swimming May Be Protective of Knee Osteoarthritis: Data from the Osteoarthritis Initiative.

Authors:  Grace H Lo; Uzoh E Ikpeama; Jeffrey B Driban; Andrea M Kriska; Timothy E McAlindon; Nancy J Petersen; Kristi L Storti; Charles B Eaton; Marc C Hochberg; Rebecca D Jackson; C Kent Kwoh; Michael C Nevitt; Maria E Suarez-Almazor
Journal:  PM R       Date:  2019-12-04       Impact factor: 2.298

7.  Relationship between objectively measured lifestyle factors and health factors in patients with knee osteoarthritis: The STROBE Study.

Authors:  Ji-Na Jeong; Si-Hyun Kim; Kyue-Nam Park
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

8.  Association of blood pressure with knee cartilage composition and structural knee abnormalities: data from the osteoarthritis initiative.

Authors:  Walid Ashmeik; Gabby B Joseph; Michael C Nevitt; Nancy E Lane; Charles E McCulloch; Thomas M Link
Journal:  Skeletal Radiol       Date:  2020-03-07       Impact factor: 2.199

9.  Associations of Metabolic Syndrome and Its Components with the Risk of Incident Knee Osteoarthritis Leading to Hospitalization: A 32-Year Follow-up Study.

Authors:  Sanna Konstari; Katri Sääksjärvi; Markku Heliövaara; Harri Rissanen; Paul Knekt; Jari P A Arokoski; Jaro Karppinen
Journal:  Cartilage       Date:  2019-12-21       Impact factor: 3.117

10.  Patients with Type 2 Diabetes Exhibit a More Mineralized Deep Cartilage Layer Compared with Nondiabetic Controls: A Pilot Study.

Authors:  Sarah C Foreman; Walid Ashmeik; Joe D Baal; Misung Han; Emma Bahroos; Claudio E von Schacky; Michael Carl; Roland Krug; Gabby B Joseph; Thomas M Link
Journal:  Cartilage       Date:  2019-08-27       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.